BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 27317765)

  • 21. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
    Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
    Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.
    Dufort FJ; Gumina MR; Ta NL; Tao Y; Heyse SA; Scott DA; Richardson AD; Seyfried TN; Chiles TC
    J Biol Chem; 2014 Mar; 289(10):7011-7024. PubMed ID: 24469453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.
    Zheng W; Tasselli L; Li TM; Chua KF
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.
    Qiao C; Huang W; Chen J; Feng W; Zhang T; Wang Y; Liu D; Ji X; Xie M; Sun M; Fan D; Wu K; Xia L
    Cell Death Dis; 2021 Jun; 12(6):564. PubMed ID: 34075028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATP-citrate lyase: a key player in cancer metabolism.
    Zaidi N; Swinnen JV; Smans K
    Cancer Res; 2012 Aug; 72(15):3709-14. PubMed ID: 22787121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.
    Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate.
    Keenan MM; Liu B; Tang X; Wu J; Cyr D; Stevens RD; Ilkayeva O; Huang Z; Tollini LA; Murphy SK; Lucas J; Muoio DM; Kim SY; Chi JT
    PLoS Genet; 2015 Oct; 11(10):e1005599. PubMed ID: 26452058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting mitochondrial citrate transport in breast cancer cell lines.
    Ozkaya AB; Ak H; Atay S; Aydin HH
    Anticancer Agents Med Chem; 2015; 15(3):374-81. PubMed ID: 25511512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells.
    Chu KY; Lin Y; Hendel A; Kulpa JE; Brownsey RW; Johnson JD
    J Biol Chem; 2010 Oct; 285(42):32606-15. PubMed ID: 20693577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
    Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
    Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP citrate lyase: A central metabolic enzyme in cancer.
    Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
    Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.
    Tian Y; Ma J; Wang H; Yi X; Wang H; Zhang H; Guo S; Yang Y; Zhang B; Du J; Shi Q; Gao T; Guo W; Li C
    Cell Mol Life Sci; 2023 Oct; 80(11):315. PubMed ID: 37801083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
    Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
    Wang W; Zhou X; Wei M
    Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
    Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
    Front Immunol; 2018; 9():2858. PubMed ID: 30568658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
    Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
    Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.
    Zhou X; Wei M; Wang W
    Biochem Biophys Res Commun; 2013 Aug; 437(4):653-8. PubMed ID: 23872151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.
    Li G; Li M; Hu J; Lei R; Xiong H; Ji H; Yin H; Wei Q; Hu G
    Oncogene; 2017 Feb; 36(7):989-998. PubMed ID: 27641336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis.
    Kumari R; Deshmukh RS; Das S
    Nat Commun; 2019 Sep; 10(1):4255. PubMed ID: 31534141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.